Literature DB >> 12873769

The earliest steps in hepatitis B virus infection.

Arik Cooper1, Nir Paran, Yosef Shaul.   

Abstract

The early steps in hepatitis B virus (HBV) infection, a human hepadnavirus, initiates from cell attachment followed by entry and delivery of the genetic information to the nucleus. Despite the fact that these steps determine the virus-related pathogenesis, their molecular basis is poorly understood. Cumulative data suggest that this process can be divided to cell attachment, endocytosis, membrane fusion and post-fusion consecutive steps. These steps are likely to be regulated by the viral envelope proteins and by the cellular membrane, receptors and extracellular matrix. In the absence of animal model for HBV, the duck hepadnavirus DHBV turned out to be a fruitful animal model. Therefore data concerning the early, post-attachment steps in hepadnaviral entry are largely based on studies performed with DHBV in primary duck liver hepatocytes. These studies are now starting to illuminate the mechanisms of hepadnavirus route of cell entry and to provide some new insights on the molecular basis of the strict species specificity of hepadnavirus infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873769     DOI: 10.1016/s0005-2736(03)00166-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.

Authors:  Qiang Deng; Jian-wei Zhai; Marie-Louise Michel; Jun Zhang; Jun Qin; Yu-ying Kong; Xin-xin Zhang; Agata Budkowska; Pierre Tiollais; Yuan Wang; You-hua Xie
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

2.  Expression and purification of the complete PreS region of hepatitis B Virus.

Authors:  Qiang Deng; Yu-Ying Kong; You-Hua Xie; Yuan Wang
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

3.  CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.

Authors:  F Tacke; C Liedtke; S Bocklage; M P Manns; C Trautwein
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

4.  Establishment and assessment of two methods for quantitative detection of serum duck hepatitis B virus DNA.

Authors:  Ya-Xi Chen; Ai-Long Huang; Zhen-Yuan Qi; Shu-Hua Guo
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

5.  Establishment of mice model with human viral hepatitis B.

Authors:  Li-Fen Gao; Wen-Sheng Sun; Chun-Hong Ma; Su-Xia Liu; Xiao-Yan Wang; Li-Ning Zhang; Ying-Lin Cao; Fa-Liang Zhu; Yu-Gang Liu
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

6.  The structure of a prokaryotic viral envelope protein expands the landscape of membrane fusion proteins.

Authors:  Kamel El Omari; Sai Li; Abhay Kotecha; Thomas S Walter; Eduardo A Bignon; Karl Harlos; Pentti Somerharju; Felix De Haas; Daniel K Clare; Mika Molin; Felipe Hurtado; Mengqiu Li; Jonathan M Grimes; Dennis H Bamford; Nicole D Tischler; Juha T Huiskonen; David I Stuart; Elina Roine
Journal:  Nat Commun       Date:  2019-02-19       Impact factor: 14.919

7.  Functional incorporation of green fluorescent protein into hepatitis B virus envelope particles.

Authors:  Carsten Lambert; Nicole Thomé; Christoph J Kluck; Reinhild Prange
Journal:  Virology       Date:  2004-12-05       Impact factor: 3.616

8.  Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.

Authors:  Yu-Heng Lai; Cheng-Pu Sun; Hsiu-Chen Huang; Jui-Chieh Chen; Hui-Kang Liu; Cheng Huang
Journal:  BMC Complement Altern Med       Date:  2018-09-06       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.